{
  "dataset": "Strategic Signal — Corporate AI Data Transactions",
  "dataset_version": "1.0.12",
  "methodology_version": "1.0.0",
  "released_on": "2026-09-29",
  "observation_count": 15,
  "approved_record_count": 10,
  "change_type": "reviewed_addition",
  "previous_version": "1.0.11",
  "changes": [
    "SS-AIDT-2026-0013: Mike Ye approved the vRad → GuideAI Health canonical AI Access data-rights arrangement. GuideAI retains exclusive rights to develop AI models using de-identified imaging generated across more than 2,100 U.S. hospitals and healthcare facilities, expressly for training and validating vascular-disease algorithms. Economics, term length, retention, sublicensing and detailed derived-model ownership remain undisclosed; Human Response is not established."
  ],
  "known_limits": [
    "Only human_reviewed records count as approved observations.",
    "Bundled commitments and pending bids are not dataset purchase prices."
  ]
}